Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 5 - Jul 10
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Dr. Reddy Mintop 2.5 30TabletProduct introduction Mintop Tablet is a vasodilator used in the treatment of certain hypertension cases. It is generally used as a second line treatment when other antihypertensive medicines have not been effective or are not suitable for a patient. It relaxes and widens the blood vessels, allowing blood to flow more easily. Mintop Tablet may be taken with or without food. Take it in the exact dose and duration for as long as your doctor has
Product introduction
Mintop Tablet is a vasodilator used in the treatment of certain hypertension cases. It is generally used as a second-line treatment when other antihypertensive medicines have not been effective or are not suitable for a patient. It relaxes and widens the blood vessels, allowing blood to flow more easily.
Mintop Tablet may be taken with or without food. Take it in the exact dose and duration for as long as your doctor has prescribed for maximum benefits. Do not stop taking the medicine until you have finished the complete course. The effects are lost if the medication is stopped.
Some common side effects of this medicine include low blood pressure, headache, excessive hair growth, weight gain, fast heart rate, low platelet count, decreased white blood cells, and ECG changes. While on treatment with this medicine, the doctor may advise regular monitoring of its effects and adjust the dosage as needed.
Mintop Tablet may not be suitable for everyone. To make sure it is safe for you, let the doctor know about all the other medications you are taking. Let the doctor also know if you have any preexisting medical conditions. Pregnant and breastfeeding women should consult their doctors before using this medicine.
Mintop Tablet may be taken with or without food. Take it in the exact dose and duration for as long as your doctor has prescribed for maximum benefits. Do not stop taking the medicine until you have finished the complete course. The effects are lost if the medication is stopped.
Some common side effects of this medicine include low blood pressure, headache, excessive hair growth, weight gain, fast heart rate, low platelet count, decreased white blood cells, and ECG changes. While on treatment with this medicine, the doctor may advise regular monitoring of its effects and adjust the dosage as needed.
Mintop Tablet may not be suitable for everyone. To make sure it is safe for you, let the doctor know about all the other medications you are taking. Let the doctor also know if you have any preexisting medical conditions. Pregnant and breastfeeding women should consult their doctors before using this medicine.
Uses of Mintop Tablet
Benefits of Mintop Tablet
In Treatment of Hypertension (high blood pressure)
Mintop Tablet helps lower blood pressure by relaxing and widening the blood vessels, reducing peripheral vascular resistance. It is particularly useful in certain cases of resistant hypertension when other antihypertensive medications do not work or are contraindicated.
Side effects of Mintop Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Mintop
- Hypotension (low blood pressure)
- Headache
- Hypertrichosis (excessive hair growth)
- Weight gain
- Tachycardia
- Decreased white blood cell count
- ECG changes
How to use Mintop Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mintop Tablet may be taken with or without food, but it is better to take it at a fixed time.
How Mintop Tablet works
Mintop Tablet belongs to the class of medicine known as potassium channel openers. It is an antihypertensive peripheral vasodilator. It works by opening adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells. This helps to dilate the arteries (blood vessels) to increase the blood flow and to decrease the blood pressure.
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.3 ★★★★★
Based on 828 reviews
Sort
Product Reviews
★★★★★ 2
Needs editing
Format: Kindle
Cute storyline and promising characters, but the lack of editing is painful to read. I would love to read an edited version.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 10, 2025
★★★★★ 5
ABSOLUTELY A MUST for Omegaverse Girls!!!
I ABSOLUTELY LOVE Jillian West and her books!!! I’m so happy I already bought book two and now I have to buy the others for the Assurance Security series!!
Not gonna lie Val kind of annoyed me at the beginning but she grew on me!! Her men are chef’s kisses!!! Holt annoys me some but I can let it slide. I already bought part two so I’m going to be reading that in between work phone calls!!!! DON’T TELL MY BOSS 😂😂😂😂
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 30, 2025
★★★★★ 4
Baby bumps and bodyguards
Format: Kindle
Dark, emotional, and unexpectedly tender, Not Ready is an omegaverse romance that delivers found family feels, fierce protectiveness, and a very pregnant heroine who refuses to break. Vale’s on the run from a stalker, but lands in the arms of three private security alphas, cue the swoony tension, fake marriage twist, and slow-burn heat.
It’s a little gritty, a little soft, and a whole lot addictive. If you love protective alphas, high stakes, and heroines with quiet strength, this one’s a must-read.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 18, 2025
★★★★★ 5
Strong Omegaverse Comfort and a Attention Grabbing Plot
Format: Kindle
Jillian West never misses when it comes to Omegaverse, and Not Ready is no exception. This story was the perfect blend of cozy comfort and emotional depth while still delivering a strong plot.
Vale is such a powerful heroine, she is strong, capable, and determined but I love that she still allows her pack to love and take care of her. It’s that balance of independence and vulnerability that makes her so relatable.
The relationship dynamics were amazing: Bishop is steadfast and completely head over heels, Mercy is skeptical but protective in his own way, and Holt is the hesitant one whose slow fall is so satisfying to watch unfold.
The romance hits that sweet spot between insta-love and cautious build, keeping me hooked the entire way through. And that ending. Oh my god, the cliffhanger! I need the next book in this duet immediately.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on August 28, 2025
★★★★★ 5
Interesting
Format: Kindle
So I will say I enjoyed the story, for sure had its moments where it dragged but it was a great story. I really liked that omegas picked their alphas/make the pack. Normally the Alphas make it and the omega fits in with them which is great but I enjoyed this new version where all the power basically went to the omega. It was a nice change of pace. I can admit some of the weird bedroom stuff with her being pregnant was odd, it’s really not hard to do stuff when pregnant (I know I’ve had two and it’s normal and even encouraged at the end especially if you want the baby out). But I like the story as a whole and will read the second, I do hope the next one isn’t dragged bc it stopped being action or tense after she met her alphas and I don’t think it was brought up or properly done when they tried to do it. More sweet after she left.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 11, 2024